Related Experiment Video
Updated: Feb 27, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis
Yixin Zhou1, Xin Zhong1,2, Zhijie Mao1
1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, The Key Laboratory of Cardiovascular Disease of Wenzhou, Wenzhou, China.
Background:
Ageing is a significant risk factor for pathophysiological alterations in the heart, but the intrinsic mechanisms by which these occur have yet to be fully elucidated. Purinergic 2×7 receptor (P2X7R) is important for the pathogenesis of numerous cardiovascular diseases; nevertheless, its function in the process of cardiac ageing remains uncertain.
Methods:
This study utilised P2X7R knockout (P2X7R-/-) mice. An ageing model was established by either maintaining mice until they reached 20 months of age or performing chronic subcutaneous injection of D-galactose (D-gal). Recombinant adeno-associated virus serotype 9 (AAV9) was employed to achieve cardiac-specific overexpression of P2X7R and nuclear receptor subfamily 4 group A member 1 (NR4A1). Cardiac function and histopathological changes in cardiac tissues were evaluated. Transcriptome sequencing was further applied to elucidate the potential mechanisms of P2X7R in cardiac senescence.
Result:
Our result show that serum levels of P2X7R increase with advancing age in humans and that P2X7R expression is upregulated during cardiac senescence in mice. P2X7R deficiency alleviates ageing-related cardiac dysfunction, senescence phenotypes and impaired mitophagy. Cardiomyocyte-specific overexpression of P2X7R with AAV9 exacerbates the myocardial dysfunction, senescence phenotype and mitophagy disruption induced by D-gal. Mechanistically, P2X7R promotes human antigen R (HuR) nucleocytoplasmic shuttling in ageing hearts, thereby increasing the mRNA stability of tripartite motif containing 26 (TRIM26) and the expression of the E3 ubiquitin ligase TRIM26. TRIM26 subsequently mediates NR4A1 ubiquitination, leading to its proteasomal degradation, which subsequently suppresses mitophagy in cardiomyocytes and ultimately accelerates cardiac ageing.
Conclusions:
Our findings provide valuable insights into the role of P2X7R in cardiac ageing and identify the HuR/TRIM26/NR4A1 axis as a key signalling pathway through which P2X7R regulates cardiac ageing.
Insights
The purinergic 2×7 receptor (P2X7R) accelerates cardiac ageing by promoting the HuR/TRIM26/NR4A1 pathway, leading to impaired mitophagy. Inhibiting P2X7R may offer therapeutic benefits for age-related heart dysfunction.
Area of Science:
- Cardiovascular Biology
- Aging Research
- Molecular Mechanisms of Disease
Background:
- Cardiac ageing involves complex pathophysiological alterations with incompletely understood mechanisms.
- The purinergic 2×7 receptor (P2X7R) is implicated in cardiovascular diseases, but its role in cardiac ageing is unclear.
Purpose of the Study:
- To investigate the function of P2X7R in the process of cardiac ageing.
- To elucidate the molecular pathways regulated by P2X7R in senescent hearts.
Main Methods:
- Utilized P2X7R knockout mice and a D-galactose-induced ageing model.
- Employed cardiac-specific overexpression of P2X7R and NR4A1 using AAV9.
- Evaluated cardiac function, histopathology, and performed transcriptome sequencing.
Main Results:
- P2X7R expression and serum levels increase with age and cardiac senescence.
- P2X7R deficiency improved cardiac function and mitophagy in aged mice.
- P2X7R overexpression exacerbated age-related cardiac dysfunction and mitophagy impairment.
- Identified the HuR/TRIM26/NR4A1 axis as a key P2X7R-regulated pathway impacting mitophagy.
Conclusions:
- P2X7R plays a critical role in accelerating cardiac ageing.
- The HuR/TRIM26/NR4A1 signaling axis is a key mediator of P2X7R's effects on cardiac senescence.
- Targeting P2X7R may be a therapeutic strategy for age-related cardiac dysfunction.
More Related Videos
08:15Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018